Updated time: 2021-11-24 14:29:22
12T-1030101
Know-how
PEG (polyethylene glycol) is a water-soluble, nontoxic, biocompatible polymer that has been approved by the Food and Drug Administration (FDA) for human intravenous, oral and dermal applications. Attachment of PEG to peptides, proteins, nucleic acids and nanomedicines can minimize proteolytic degradation and increase serum half-life. We developed monoclonal antibodies that specifically bind to PEG with high affinity and selectivity.
Monoclonal antibodies with specificity for PEG can be used to assay the concentrations of PEGylated compounds in biological samples by ELISA. Anti-PEG antibodies can also be used as affinity capture reagents to concentrate PEGylated compounds for further analysis by many techniques. The antibodies can also be employed to detect and quantify PEG-modified molecules in immunoblots and by flow cytometry. We have also developed humanized antibodies that can be used as reference standards in assays to measure ADA (anti-drug antibodies). Several classes of human antibodies are available including IgM, IgG1, IgG2, IgG3, IgG4 and IgE. Biotinylated versions of the antibodies are also available to act as detection agents.
Technological Advantages
Advantages and price, please refer the following web site: http://www.ibms.sinica.edu.tw/~sroff/anti-PEG/index.html
Steve Roffler, Tian-Lu Cheng, Bing-Mae Chen
If you are interested in this technology, please fill in the information on the webpage under the manufacturer option (Request for Technology Licensing, Material Transfer, or Sponsored Research) on the website of this office

Anti-PEG Antibodies